Cardio Diagnostics Holdings Inc CDIO.OQ CDIO.O is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending March 31 2025
The Chicago Illinois-based company is expected to report a 213.9% increase in revenue to $50 thousand from $15.93 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Cardio Diagnostics Holdings Inc is for a loss of $1.80 per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cardio Diagnostics Holdings Inc is $60.00, above its last closing price of $4.00.
This summary was machine generated May 16 at 20:56 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)